Manuel Counson
Esch-sur-alzette, ES L4354, Luxembourg
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Physical interaction with Ephrin B1 promotes CXCR4 intracellular localization and oncogenic potential.
Journal: Cellular and molecular life sciences : CMLS
Published: July 17, 2025
Novel Small-Molecule Atypical Chemokine Receptor 3 Agonists: Design, Synthesis, and Pharmacological Evaluation for Antiplatelet Therapy.
Journal: Journal of medicinal chemistry
Published: August 08, 2024
Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
Journal: Biochemical pharmacology
Published: February 11, 2018
Development of Mimokines, chemokine N terminus-based CXCR4 inhibitors optimized by phage display and rational design.
Journal: Journal of leukocyte biology
Published: January 05, 2018
Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
Journal: British journal of pharmacology
Published: March 28, 2017
Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Journal: Biochemical pharmacology
Published: February 26, 2016
Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller.
Journal: AIDS (London, England)
Published: January 14, 2016
Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection.
Journal: Biochimica et biophysica acta
Published: July 15, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026